|
Market Closed -
NYSE
16:00:02 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 81.33 USD | -2.67% |
|
-4.78% | +2.64% |
| 10-19 | Solventum Receives FDA Clearance for Combined Use of Wound Care Technologies | MT |
| 10-19 | Solventum Secures FDA Clearance for Combined Wound Care Technologies | DJ |
| Market Cap | 13.84B 12.4B 11.41B 10.33B 19.32B 1,315B 19.68B 136B 54.6B 691B 51.96B 50.85B 2,181B | P/E 2026 * |
47.7x | P/E 2027 * | 21.3x |
|---|---|---|---|---|---|
| Enterprise Value | 18.72B 16.77B 15.42B 13.97B 26.12B 1,778B 26.61B 184B 73.83B 935B 70.26B 68.76B 2,949B | EV / Sales 2026 * |
2.28x | EV / Sales 2027 * | 2.13x |
| Free-Float |
82.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| SOLV | Delayed | |
CBOE
| SOLV | Real-time | |
|
Boerse Muenchen
| KB7 | Real-time | |
|
Mexican S.E.
| SOLV * | End-of-day quote | |
|
Tradegate
| KB7 | Real-time | |
|
Börse Stuttgart
| KB7 | End-of-day quote | |
|
Börse Stuttgart
| KB7 | Delayed | |
|
Deutsche Boerse AG
| KB7 | Delayed | |
|
Deutsche Boerse AG
| KB7 | End-of-day quote | |
|
Borsa Italiana
| 1SOLV | End-of-day quote |
Last Transcript: Solventum Corporation
| 1 day | -2.67% | ||
| 1 week | -4.78% | ||
| 1 month | -7.34% | ||
| 3 months | -4.81% | ||
| 6 months | +22.06% | ||
| Current year | +2.64% |
| 1 week | 80.76 |  | 85.81 |
| 1 month | 80.76 | | 89.45 |
| Current year | 62.38 | | 94.16 |
| 1 year | 62.38 | | 94.16 |
| 3 years | 47.16 | | 96.05 |
| 5 years | 47.16 | | 96.05 |
| 10 years | 47.16 | | 96.05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Exercice | Chief Executive Officer | 160,990 | 0.0930% | ||
| 8/17/26 | Free | Controller/Auditor | 6,911 | 0.0040% | ||
| 5/15/26 | Free | Director | 3,300 | 0.0019% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.67% | -4.78% | +17.80% | - | 13.84B | |
| +1.56% | +2.41% | -14.09% | +11.78% | 184B | |
| -0.59% | +1.18% | +6.44% | +36.26% | 118B | |
| -6.38% | -4.98% | -18.07% | +7.28% | 111B | |
| +3.42% | +1.71% | -41.92% | +7.51% | 94.58B | |
| +0.09% | -0.05% | -2.06% | +76.70% | 63.13B | |
| -5.09% | -4.67% | -0.99% | +62.63% | 55.66B | |
| -0.23% | -0.52% | +10.73% | -22.03% | 53.9B | |
| -4.30% | -1.64% | -12.44% | +39.42% | 43.42B | |
| +0.58% | +2.00% | -1.17% | -9.88% | 34.68B | |
| Average | -1.36% | -0.43% | -5.58% | +23.30% | 77.23B | |
| Weighted average by Cap. | -0.85% | +0.15% | -10.03% | +21.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.23B 7.37B 6.78B 6.14B 11.48B 781B 11.69B 80.82B 32.44B 411B 30.87B 30.22B 1,296B | 8.52B 7.63B 7.02B 6.36B 11.89B 809B 12.11B 83.7B 33.6B 426B 31.97B 31.3B 1,342B |
| Net income | 300M 269M 247M 224M 419M 28.51B 427M 2.95B 1.18B 15B 1.13B 1.1B 47.29B | 652M 584M 537M 487M 910M 61.89B 927M 6.4B 2.57B 32.56B 2.45B 2.39B 103B |
| Net Debt | 4.88B 4.37B 4.02B 3.64B 6.8B 463B 6.93B 47.91B 19.23B 244B 18.3B 17.91B 768B | 4.27B 3.83B 3.52B 3.19B 5.96B 406B 6.08B 41.99B 16.86B 214B 16.04B 15.7B 673B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$81.33 | -2.67% | 1,067,230 |
| 26-10-29 | US$83.56 | +2.09% | 1,088,684 |
| 26-10-28 | US$81.85 | -1.36% | 1,565,369 |
| 26-10-27 | US$82.98 | -3.30% | 1,320,156 |
| 26-10-26 | US$85.81 | +0.47% | 975,574 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SOLV Stock
Select your edition
All financial news and data tailored to specific country editions
